Display options
Cite
Marren AS. Tofacitinib is not a biologic. Ann Gastroenterol. 2016;30(1):134doi: 10.20524/aog.2016.0094.
Marren, A. S. (2017). Tofacitinib is not a biologic. Annals of gastroenterology, 30(1), 134. https://doi.org/10.20524/aog.2016.0094
Marren, Amy S. "Tofacitinib is not a biologic." Annals of gastroenterology vol. 30,1 (2017): 134. doi: https://doi.org/10.20524/aog.2016.0094
Marren AS. Tofacitinib is not a biologic. Ann Gastroenterol. 2017;30(1):134. doi: 10.20524/aog.2016.0094. Epub 2016 Oct 07. PMID: 28042254; PMCID: PMC5198242.
Copy Download .nbib Format: NLM
Share it on

Ann Gastroenterol. 2017;30(1):134. doi: 10.20524/aog.2016.0094. Epub 2016 Oct 07.

Tofacitinib is not a biologic.

Annals of gastroenterology

Amy S Marren

Affiliations

  1. Medical Lead/Team Leader Gastroenterology, Global Medical Affairs, Pfizer Inc, PA, USA.

PMID: 28042254 PMCID: PMC5198242 DOI: 10.20524/aog.2016.0094

[No abstract available.]

Conflict of interest statement

Amy S. Marren is an employee and shareholder of Pfizer Inc

References

  1. Ann Gastroenterol. 2016 Jul-Sep;29(3):243-8 - PubMed

Publication Types